Aug 25 (Reuters) - Beigene Ltd:
* SAY CO, UNIT SIGN ROYALTY PURCHASE AGREEMENT WITH ROYALTY
PHARMA
INVESTMENTS 2023 ICAV, UNIT OF ROYALTY PHARMA PLC
* SAYS AGREED TO SELL RIGHTS TO ROYALTIES ON IMDELLTRA SALES
OUTSIDE CHINA TO ROYALTY PHARMA INVESTMENTS 2023 ICAV FOR $885
MILLION UPFRONT
Source text
Further company coverage:
(Reporting by Beijing Newsroom)